Viral vectors for gene therapy: Current state and clinical perspectives
Tóm tắt
Gene therapy is the straightforward approach for the application of recent advances in molecular biology into clinical practice. One of the major obstacles in the development of gene therapy is the delivery of the effector to and into the target cell. Unfortunately, most methods commonly used in laboratory practice are poorly suited for clinical use. Viral vectors are one of the most promising methods for gene therapy delivery. Millions of years of evolution of viruses have resulted in the development of various molecular mechanisms for entry into cells, long-term survival within cells, and activation, inhibition, or modification of the host defense mechanisms at all levels. The relatively simple organization of viruses, small genome size, and evolutionary plasticity allow modifying them to create effective instruments for gene therapy approaches. This review summarizes the latest trends in the development of gene therapy, in particular, various aspects and prospects of the development of clinical products based on viral delivery systems.
Tài liệu tham khảo
citation_journal_title=Biochemistry (Moscow); citation_title=Prospects for using self-assembled nucleic acid structures; citation_author=M. N. Rudchenko, A. A. Zamyatnin; citation_volume=80; citation_publication_date=2015; citation_pages=391-399; citation_doi=10.1134/S000629791504001X; citation_id=CR1
citation_journal_title=Nature; citation_title=An autonomous molecular computer for logical control of gene expression; citation_author=Y. Benenson, B. Gil, U. Ben-Dor, R. Adar, E. Shapiro; citation_volume=429; citation_publication_date=2004; citation_pages=423-429; citation_doi=10.1038/nature02551; citation_id=CR2
citation_journal_title=Sci. Rep.; citation_title=A library of programmable DNAzymes that operate in a cellular environment; citation_author=M. Kahan-Hanum, Y. Douek, R. Adar, E. Shapiro; citation_volume=3; citation_publication_date=2013; citation_pages=1535; citation_doi=10.1038/srep01535; citation_id=CR3
citation_journal_title=Science; citation_title=A programmable dualRNA-guided DNA endonuclease in adaptive bacterial immunity; citation_author=M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J. A. Doudna, E. Charpentier; citation_volume=337; citation_publication_date=2012; citation_pages=816-821; citation_doi=10.1126/science.1225829; citation_id=CR4
citation_journal_title=Biochemistry (Moscow); citation_title=Diversity of mechanisms of CRISPR-Cas systems of adaptiv immunity of procaryotes and possibilities to use them in biotechnology; citation_author=E. E. Savitskaya, O. S. Musharova, K. V. Severinov; citation_volume=81; citation_publication_date=2016; citation_pages=653-661; citation_doi=10.1134/S0006297916050023; citation_id=CR5
citation_journal_title=Nat. Rev. Clin. Oncol.; citation_title=Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer; citation_author=C. G. Drake, E. J. Lipson, J. R. Brahmer; citation_volume=11; citation_publication_date=2014; citation_pages=24-37; citation_doi=10.1038/nrclinonc.2013.208; citation_id=CR6
citation_journal_title=Nature; citation_title=Cancer immunotherapy comes of age; citation_author=I. Mellman, G. Coukos, G. Dranoff; citation_volume=480; citation_publication_date=2011; citation_pages=480-489; citation_doi=10.1038/nature10673; citation_id=CR7
citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_title=Adenovirus as an expression vector in muscle cells in vivo; citation_author=B. Quantin, L. D. Perricaudet, S. Tajbakhsh, J. L. Mandel; citation_volume=89; citation_publication_date=1992; citation_pages=2581-2584; citation_doi=10.1073/pnas.89.7.2581; citation_id=CR8
citation_title=Gene Therapy; citation_publication_date=2010; citation_id=CR9; citation_author=M. Giacca
citation_journal_title=Curr. Opin. Mol. Ther.; citation_title=Adenovirusmediated transfer of regulable gene expression; citation_author=S. Y. Tsai, K. Schillinger, X. Ye; citation_volume=2; citation_publication_date=2000; citation_pages=515-523; citation_id=CR10
citation_journal_title=Mol. Ther.; citation_title=Adenovirus type 5 interactions with human blood cells may compromise systemic delivery; citation_author=M. Lyons, D. Onion, N. K. Green, K. Aslan, R. Rajaratnam, M. Bazan-Peregrino, S. Phipps, S. Hale, V. Mautner, L. W. Seymour, K. D. Fisher; citation_volume=14; citation_publication_date=2006; citation_pages=118-128; citation_doi=10.1016/j.ymthe.2006.01.003; citation_id=CR11
citation_journal_title=Hum. Gene Ther.; citation_title=Innate immunity to adenovirus; citation_author=R. Hendrickx, N. Stichling, J. Koelen, L. Kuryk, A. Lipiec, U. F. Greber; citation_volume=25; citation_publication_date=2014; citation_pages=265-284; citation_doi=10.1089/hum.2014.001; citation_id=CR12
citation_journal_title=Mol. Genet. Metab.; citation_title=Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer; citation_author=S. E. Raper, N. Chirmule, F. S. Lee, N. A. Wivel, A. Bagg, G. P. Gao, J. M. Wilson, M. L. Batshaw; citation_volume=80; citation_publication_date=2003; citation_pages=148-158; citation_doi=10.1016/j.ymgme.2003.08.016; citation_id=CR13
citation_journal_title=Clin. Diagn. Lab. Immunol.; citation_title=Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States; citation_author=E. Nwanegbo, E. Vardas, W. Gao, H. Whittle, H. Sun, D. Rowe, P. D. Robbins, A. Gambotto; citation_volume=11; citation_publication_date=2004; citation_pages=351-357; citation_id=CR14
citation_journal_title=J. Virol. Methods; citation_title=Rescue of chimeric adenoviral vectors to expand the serotype repertoire; citation_author=S. Roy, D. S. Clawson, O. Lavrukhin, A. Sandhu, J. Miller, J. M. Wilson; citation_volume=141; citation_publication_date=2007; citation_pages=14-21; citation_doi=10.1016/j.jviromet.2006.11.022; citation_id=CR15
citation_journal_title=Science; citation_title=T-lymphocytedirected gene therapy for ADA-SCID: initial trial results after 4 years; citation_author=R. M. Blaese, K. W. Culver, A. D. Miller, C. S. Carter, T. Fleisher, M. Clerici, G. Shearer, L. Chang, Y. Chiang, P. Tolstoshev, J. J. Greenblatt, S. A. Rosenberg, H. Klein, M. Berger, C. A. Mullen, W. J. Ramsey, L. Muul, R. A. Morgan, W. F. Anderson; citation_volume=270; citation_publication_date=1995; citation_pages=475-480; citation_doi=10.1126/science.270.5235.475; citation_id=CR16
citation_journal_title=Science; citation_title=Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients; citation_author=C. Bordignon, L. D. Notarangelo, N. Nobili, G. Ferrari, G. Casorati, P. Panina, E. Mazzolari, D. Maggioni, C. Rossi, P. Servida, A. G. Ugazio, F. Mavilio; citation_volume=270; citation_publication_date=1995; citation_pages=470-475; citation_doi=10.1126/science.270.5235.470; citation_id=CR17
citation_journal_title=Nat. Med.; citation_title=Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency; citation_author=D. B. Kohn, K. I. Weinberg, J. A. Nolta, L. N. Heiss, C. Lenarsky, G. M. Crooks, M. E. Hanley, G. Annett, J. S. Brooks, A. El-Khoureiy, K. Lawrence, D. Wells, R. C. Moen, J. Bastian, D. E. Williams-Herman, M. Elder, D. Wara, T. Bowen, M. S. Hershfield, C. A. Mullen, R. M. Blaese, R. Parkman; citation_volume=1; citation_publication_date=1995; citation_pages=1017-1023; citation_doi=10.1038/nm1095-1017; citation_id=CR18
citation_journal_title=Blood; citation_title=Hot spots of retroviral integration in human CD34+ hematopoietic cells; citation_author=C. Cattoglio, G. Facchini, D. Sartori, A. Antonelli, A. Miccio, B. Cassani, M. Schmidt, C. Kalle, S. Howe, A. J. Thrasher, A. Aiuti, G. Ferrari, A. Recchia, F. Mavilio; citation_volume=110; citation_publication_date=2007; citation_pages=1770-1778; citation_doi=10.1182/blood-2007-01-068759; citation_id=CR19
citation_journal_title=Blood; citation_title=Highdefinition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors; citation_author=C. Cattoglio, D. Pellin, E. Rizzi, G. Maruggi, G. Corti, F. Miselli, D. Sartori, A. Guffanti, C. Serio, A. Ambrosi, G. Bellis, F. Mavilio; citation_volume=116; citation_publication_date=2010; citation_pages=5507-5517; citation_doi=10.1182/blood-2010-05-283523; citation_id=CR20
citation_journal_title=Science; citation_title=Transcription start regions in the human genome are favored targets for MLV integration; citation_author=X. Wu, Y. Li, B. Crise, S. M. Burgess; citation_volume=300; citation_publication_date=2003; citation_pages=1749-1751; citation_doi=10.1126/science.1083413; citation_id=CR21
citation_journal_title=J. Clin. Invest.; citation_title=Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1; citation_author=S. Hacein-Bey-Abina, A. Garrigue, G. P. Wang, J. Soulier, A. Lim, E. Morillon, E. Clappier, L. Caccavelli, E. Delabesse, K. Beldjord, V. Asnafi, E. Macintyre, L. Cortivo, I. Radford, N. Brousse, F. Sigaux, D. Moshous, J. Hauer, A. Borkhardt, B. H. Belohradsky, U. Wintergerst, M. C. Velez, L. Leiva, R. Sorensen, N. Wulffraat, S. Blanche, F. D. Bushman, A. Fischer, M. Cavazzana-Calvo; citation_volume=118; citation_publication_date=2008; citation_pages=3132-3142; citation_doi=10.1172/JCI35700; citation_id=CR22
citation_journal_title=Nat. Biotechnol.; citation_title=Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration; citation_author=E. Montini, D. Cesana, M. Schmidt, F. Sanvito, M. Ponzoni, C. Bartholomae, L. Sergi Sergi, F. Benedicenti, A. Ambrosi, C. Serio, C. Doglioni, C. Kalle, L. Naldini; citation_volume=24; citation_publication_date=2006; citation_pages=687-696; citation_doi=10.1038/nbt1216; citation_id=CR23
citation_journal_title=Science; citation_title=In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector; citation_author=L. Naldini, U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, D. Trono; citation_volume=272; citation_publication_date=1996; citation_pages=263-267; citation_doi=10.1126/science.272.5259.263; citation_id=CR24
citation_journal_title=Proc. Natl. Acad. Sci. USA; citation_title=Development of HIV vectors for anti-HIV gene therapy; citation_author=E. Poeschla, P. Corbeau, F. Wong-Staal; citation_volume=93; citation_publication_date=1996; citation_pages=11395-11399; citation_doi=10.1073/pnas.93.21.11395; citation_id=CR25
citation_journal_title=Virology; citation_title=Self-inactivating lentiviral vectors with U3 and U5 modifications; citation_author=T. Iwakuma, Y. Cui, L. J. Chang; citation_volume=261; citation_publication_date=1999; citation_pages=120-132; citation_doi=10.1006/viro.1999.9850; citation_id=CR26
citation_journal_title=Hum. Gene Ther.; citation_title=Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: implications for gene therapy using AAV vectors; citation_author=C. L. Halbert, A. D. Miller, S. McNamara, J. Emerson, R. L. Gibson, B. Ramsey, M. L. Aitken; citation_volume=17; citation_publication_date=2006; citation_pages=440-447; citation_doi=10.1089/hum.2006.17.440; citation_id=CR27
citation_journal_title=Expert Opin. Biol. Ther.; citation_title=Strategies to circumvent humoral immunity to adenoassociated viral vectors; citation_author=L. V. Tse, S. Moller-Tank, A. Asokan; citation_volume=15; citation_publication_date=2015; citation_pages=845-855; citation_doi=10.1517/14712598.2015.1035645; citation_id=CR28
citation_journal_title=Acta Biomater.; citation_title=Controlled release strategies for rAAV-mediated gene delivery; citation_author=A. Rey-Rico, M. Cucchiarini; citation_volume=29; citation_publication_date=2016; citation_pages=1-10; citation_doi=10.1016/j.actbio.2015.10.015; citation_id=CR29
citation_journal_title=Nat. Rev. Genet.; citation_title=Engineering adeno-associated viruses for clinical gene therapy; citation_author=M. A. Kotterman, D. V. Schaffer; citation_volume=15; citation_publication_date=2014; citation_pages=445-451; citation_doi=10.1038/nrg3742; citation_id=CR30
citation_journal_title=Viruses; citation_title=The evolution of poxvirus vaccines; citation_author=L. Sanchez-Sampedro, B. Perdiguero, E. Mejias-Perez, J. Garcia-Arriaza, M. Pilato, M. Esteban; citation_volume=7; citation_publication_date=2015; citation_pages=1726-1803; citation_doi=10.3390/v7041726; citation_id=CR31
citation_journal_title=Oncol. Rep.; citation_title=Efficacy of oncolytic reovirus against human breast cancer cells; citation_author=Y. Hata, T. Etoh, M. Inomata, N. Shiraishi, A. Nishizono, S. Kitano; citation_volume=19; citation_publication_date=2008; citation_pages=1395-1398; citation_id=CR32
citation_journal_title=Mol. Ther.; citation_title=MAPK signal-integrating kinase controls capindependent translation and cell type-specific cytotoxicity of an oncolytic poliovirus; citation_author=C. Goetz, R. G. Everson, L. C. Zhang, M. Gromeier; citation_volume=18; citation_publication_date=2010; citation_pages=1937-1946; citation_doi=10.1038/mt.2010.145; citation_id=CR33
citation_journal_title=Curr. Pharm. Biotechnol.; citation_title=Pro-oncogenic cell signaling machinery as a target for oncolytic viruses; citation_author=E. Borrego-Diaz, R. Mathew, D. Hawkinson, T. Esfandyari, Z. Liu, P. W. Lee, F. Farassati; citation_volume=13; citation_publication_date=2012; citation_pages=1742-1749; citation_doi=10.2174/138920112800958788; citation_id=CR34
citation_journal_title=Mol. Oncol.; citation_title=Transcription factors down-stream of Ras as molecular indicators for targeting malignancies with oncolytic herpes virus; citation_author=T. Esfandyari, A. Tefferi, A. Szmidt, T. Alain, P. Zwolak, T. Lasho, P. W. Lee, F. Farassati; citation_volume=3; citation_publication_date=2009; citation_pages=464-468; citation_doi=10.1016/j.molonc.2009.07.002; citation_id=CR35
citation_journal_title=Adv. Genet.; citation_title=Methods for gene transfer to the central nervous system; citation_author=B. Kantor, R. M. Bailey, K. Wimberly, S. N. Kalburgi, S. J. Gray; citation_volume=87; citation_publication_date=2014; citation_pages=125-197; citation_doi=10.1016/B978-0-12-800149-3.00003-2; citation_id=CR36
citation_journal_title=Adv. Genet.; citation_title=Physical methods for gene transfer; citation_author=M. Alsaggar, D. Liu; citation_volume=89; citation_publication_date=2015; citation_pages=1-24; citation_doi=10.1016/bs.adgen.2014.10.001; citation_id=CR37
citation_journal_title=Biochemistry (Moscow); citation_title=Using mRNAs for therapy–achivements and perspectives; citation_author=O. V. Sergeeva, V. E. Koteliansky, T. S. Zatsepin; citation_volume=81; citation_publication_date=2016; citation_pages=709-722; citation_id=CR38
citation_journal_title=Bioconj. Chem.; citation_title=Effects of chemically modified messenger RNA on protein expression; citation_author=B. Li, X. Luo, Y. Dong; citation_volume=27; citation_publication_date=2016; citation_pages=849-853; citation_doi=10.1021/acs.bioconjchem.6b00090; citation_id=CR39
citation_journal_title=Science; citation_title=Gene therapy caught in more entanglements; citation_author=N. Wade; citation_volume=212; citation_publication_date=1981; citation_pages=24-25; citation_doi=10.1126/science.6259731; citation_id=CR40
citation_journal_title=Science; citation_title=Gene therapy death prompts review of adenovirus vector; citation_author=E. Marshall; citation_volume=286; citation_publication_date=1999; citation_pages=2244-2245; citation_doi=10.1126/science.286.5448.2244; citation_id=CR41
citation_journal_title=Curr. Cancer Drug Targets; citation_title=Clinical trials with oncolytic adenovirus in China; citation_author=W. Yu, H. Fang; citation_volume=7; citation_publication_date=2007; citation_pages=141-148; citation_doi=10.2174/156800907780058817; citation_id=CR42
citation_journal_title=Remedium; citation_title=Medicines for advanced therapies: scientific approaches to validate quality, safety and efficacy; citation_author=A. N. Mironov, A. N. Vasiliev, D. V. Goryachev, E. V. Gavrishina, R. R. Niyasov; citation_volume=7-8; citation_publication_date=2014; citation_pages=16-24; citation_id=CR43
citation_journal_title=Adv. Exp. Med. Biol.; citation_title=Regulatory aspects of gene therapy and cell therapy products: a global perspective; citation_author=M. C. Galli, M. Serabian; citation_volume=871; citation_publication_date=2014; citation_pages=1-221; citation_id=CR44
citation_journal_title=Br. J. Pharmacol.; citation_title=Physical methods of nucleic acid transfer: general concepts and applications; citation_author=J. Villemejane, L. M. Mir; citation_volume=157; citation_publication_date=2009; citation_pages=207-219; citation_doi=10.1111/j.1476-5381.2009.00032.x; citation_id=CR45